No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2762954 |
chr11:35009233-35009234 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs184663350 |
chr11:35009244-35009245 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs112606585 |
chr11:35009255-35009256 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs145553787 |
chr11:35009276-35009277 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs372421099 |
chr11:35009277-35009278 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs569825560 |
chr11:35009279-35009280 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs143653841 |
chr11:35009296-35009297 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs10836327 |
chr11:35009297-35009298 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs11032969 |
chr11:35009301-35009302 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs558458200 |
chr11:35009313-35009314 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs137896711 |
chr11:35009323-35009324 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs149493002 |
chr11:35009340-35009341 |
Weak transcription Strong transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs190002330 |
chr11:35009483-35009484 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs574481544 |
chr11:35009489-35009490 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs543016583 |
chr11:35009497-35009498 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs143940835 |
chr11:35009499-35009500 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs576940953 |
chr11:35009557-35009558 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs181228891 |
chr11:35009558-35009559 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs184892507 |
chr11:35009602-35009603 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs2767045 |
chr11:35009615-35009616 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs112471707 |
chr11:35009655-35009656 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs542418860 |
chr11:35009696-35009697 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs562009995 |
chr11:35009717-35009718 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs531058316 |
chr11:35009731-35009732 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs550826215 |
chr11:35009755-35009756 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs564125287 |
chr11:35009779-35009780 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs368212272 |
chr11:35009822-35009823 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs552047680 |
chr11:35009825-35009826 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs371742823 |
chr11:35009854-35009855 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs141241090 |
chr11:35009857-35009858 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs534466745 |
chr11:35009959-35009960 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs548381404 |
chr11:35009980-35009981 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs568034226 |
chr11:35009981-35009982 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs189796780 |
chr11:35009984-35009985 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs556812529 |
chr11:35010002-35010003 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs374437700 |
chr11:35010042-35010043 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs377518569 |
chr11:35010051-35010052 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs557485887 |
chr11:35010105-35010106 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs201687707 |
chr11:35010106-35010107 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs200648599 |
chr11:35010109-35010110 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs113972528 |
chr11:35010110-35010111 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs181764881 |
chr11:35010120-35010121 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs57223441 |
chr11:35010121-35010122 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs201267227 |
chr11:35010122-35010123 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs146276380 |
chr11:35010180-35010181 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs566348868 |
chr11:35010191-35010192 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs574967992 |
chr11:35010256-35010257 |
Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs1011519 |
chr11:35010329-35010330 |
Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
49 |
rs1011518 |
chr11:35010469-35010470 |
Weak transcription Strong transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs80254215 |
chr11:35010532-35010533 |
Weak transcription Strong transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|